The health-related quality of life (HRQoL) of patients deteriorates with an increase in the severity of COPD, suggests a recent cross-sectional study conducted by a team of researchers from the  Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. The research analysed 218 patients in the study to find that triple therapy patients mostly showed a lower quality of life than other combination therapies. The team elaborated on their methods of counting the total scores the SGRQ, WHOQOL-BREF, EQ-5D utility index, and EQ-VAS were presented as mean ± standard deviation (SD) among different combination treatments to reach this result.